|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
IFF | Herriott Simon | Pres. Health & Bioscience | May 03 | Option Exercise | 0.00 | 1,591 | 0 | 10,625 | May 07 07:03 PM |
IFF | Herriott Simon | Pres. Health & Biosci. & Scent | Apr 05 | Option Exercise | 0.00 | 1,590 | 0 | 9,496 | Apr 09 05:26 PM |
IFF | Herriott Simon | Pres. Health & Biosci. & Scent | Apr 01 | Option Exercise | 0.00 | 1,489 | 0 | 8,367 | Apr 03 04:24 PM |
IFF | Herriott Simon | President Health & Biosciences | Apr 01 | Option Exercise | 0.00 | 1,489 | 0 | 6,894 | Apr 05 04:08 PM |
IFF | Herriott Simon | President Health & Biosciences | Feb 19 | Option Exercise | 0.00 | 617 | 0 | 5,545 | Feb 21 04:09 PM |
IFF | Herriott Simon | President Health & Biosciences | Feb 19 | Option Exercise | 0.00 | 616 | 0 | 4,979 | Feb 23 04:05 PM |
IFF | Herriott Simon | President Health & Biosciences | Feb 14 | Option Exercise | 0.00 | 525 | 0 | 4,495 | Feb 16 06:37 PM |
IFF | Herriott Simon | President Health & Biosciences | Dec 31 | Option Exercise | 0.00 | 3,241 | 0 | 4,852 | Jan 04 06:35 PM |
IFF | Herriott Simon | President Health & Biosciences | May 13 | Option Exercise | 115.48 | 1,513 | 174,721 | 2,847 | May 17 05:28 PM |
IFF | Herriott Simon | President Health & Biosciences | May 13 | Sale | 138.47 | 1,332 | 184,442 | 1,515 | May 17 05:28 PM |
IFF | Herriott Simon | President Health & Biosciences | Feb 19 | Option Exercise | 0.00 | 616 | 0 | 1,038 | Feb 23 05:34 PM |
IFF | Herriott Simon | President Health & Biosciences | Feb 14 | Option Exercise | 0.00 | 525 | 0 | 525 | Feb 17 09:14 PM |
IFF | Herriott Simon | President Health & Biosciences | Feb 15 | Option Exercise | 0.00 | 105 | 0 | 457 | Feb 17 09:14 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite